Ashwagandha Extract Testing: Root vs Leaf, Withanolide Assays, and What Your CoA Should Actually Show

Ashwagandha (Withania somnifera) is one of the top-selling herbal supplements in the United States — SPINS data consistently places it in the top five botanicals by dollar volume. That commercial success has created exactly the supply chain dynamics that produce quality failures: high demand, multiple extract types competing on price, and a regulatory framework where “ashwagandha extract” on a label can mean very different things analytically.

At Qalitex, ashwagandha ranks in our top 10 most-tested botanical matrices. We see three distinct product classes come through the lab — full-spectrum root powder, root extract standardized to withanolide glycosides (e.g., KSM-66 at ≥5%), and combined root-plus-leaf extracts standardized to total withanolides (e.g., Sensoril at ≥10%). Each class requires a different analytical approach, and brands that treat them interchangeably generate CoAs that do not actually prove what their labels claim.

Root vs leaf: why the distinction is not marketing — it is chemistry

The clinical literature supporting ashwagandha’s adaptogenic and anxiolytic claims is overwhelmingly based on root material. The Indian Ayurvedic Pharmacopoeia specifies root. USP’s dietary supplement monograph for ashwagandha references root powder and root extract. When brands market “ashwagandha root extract” but purchase material that includes leaf, they create a regulatory and analytical mismatch.

For raw material and ingredient-level verification, Ayah Labs specializes in contract testing and supplier qualification.

Leaf is cheaper to produce — Withania somnifera leaves grow fast and can be harvested multiple times per season. Leaf tissue contains withanolides, but the specific withanolide profile differs from root. A 2020 study in Planta Medica (Vol. 86, pp. 601–609) compared withanolide profiles across plant parts and found that leaf extracts contained higher concentrations of withaferin A relative to withanolide A, while root material showed the inverse ratio. Withaferin A has cytotoxic properties at higher concentrations — a safety consideration that does not appear when brands assume “all withanolides are the same.”

What this means for your spec: If your master manufacturing record says “root extract” and your marketing says “root,” your identity and potency testing must confirm root-consistent chemistry. A withanolide total that hits the label number is not sufficient if the marker profile indicates leaf.

Withanolide assays: which markers, which method, which standard

This is where we see the most confusion across brands. “Withanolides” is not a single molecule — it is a family of steroidal lactones with at least 40 identified members in Withania somnifera. What your CoA reports depends entirely on:

Reference standard selection

Extract type	Typical marker	Reference standard	Expected range
Root powder (full-spectrum)	Total withanolide glycosides	USP Ashwagandha RS or Withaferin A + Withanolide A mixture	0.3–1.5%
KSM-66–type root extract	Withanolide glycosides by HPLC-UV	Supplier-provided RS matched to USP	≥ 5.0%
Sensoril-type root + leaf	Total withanolides by gravimetric or HPLC	Supplier RS or in-house validated	≥ 10.0%

The problem: three different labs using three different reference standards can report three different totals on splits of the same lot. We documented a case in Q4 2025 where a brand received withanolide results of 5.2%, 4.1%, and 6.8% from three ISO 17025 labs on the same bulk powder. The variance was method-driven, not material-driven — different extraction solvents, different integration parameters, different reference compounds.

Method validation matters

At Qalitex, we run withanolide quantitation by reversed-phase HPLC with UV detection at 227 nm, using a C18 column with methanol–water gradient. Our method is validated per ICH Q2(R1) for the ashwagandha extract matrix, with documented:

• Linearity: r² ≥ 0.999 across 50–150% of target concentration
• Accuracy: Recovery 97–103% at three spike levels
• Precision: RSD ≤ 2.0% for six replicate injections
• Specificity: Resolution ≥ 2.0 between withanolide A and adjacent peaks

If your testing lab cannot produce these validation parameters for your specific extract type, the number on the CoA is not analytically defensible.

The allergen problem brands forget until recall

In September 2024, an ashwagandha-containing supplement was recalled after an allergic reaction report revealed undeclared peanut protein as a cross-contact contaminant from shared processing equipment at the extraction facility. This was not a labeling oversight — it was a failure in supplier qualification.

Ashwagandha belongs to the Solanaceae (nightshade) family and is itself an allergen concern for nightshade-sensitive consumers. But the bigger operational risk is cross-contact at the extractor. Many ashwagandha extraction facilities in India also process:

• Peanut-derived ingredients
• Tree nut oils
• Soy-based products
• Wheat-containing formulations

Under FSMA and 21 CFR 111, supplement manufacturers must identify and control allergen hazards. Your supplier qualification program should include:

1. Allergen map of the extraction facility — what other materials run on the same lines?
2. Cleaning validation documentation from the supplier for allergen changeovers
3. Periodic testing for undeclared allergens by ELISA — at minimum during initial supplier qualification and after any process change

At Qalitex, we offer ELISA-based allergen panels (peanut, tree nut, soy, milk, egg, wheat, gluten) as an add-on to botanical identity packages. For ashwagandha specifically, we recommend peanut and soy panels on the first three lots from any new supplier, then risk-based frequency thereafter.

Heavy metals: soil background meets extraction concentration

Ashwagandha is predominantly grown in Madhya Pradesh, Rajasthan, and Gujarat — regions with variable soil cadmium and lead backgrounds. Extraction concentrates metals along with target compounds. A root powder testing at 0.3 ppm lead can yield a 10:1 extract at 2–3 ppm lead — enough to trigger Prop 65 at a 500 mg serving.

Our recommendation for ashwagandha elemental testing:

Element	Incoming raw material limit	Finished product calculation basis
Lead (Pb)	≤ 1.0 ppm (powder), ≤ 0.5 ppm (extract)	Prop 65 MADL: 0.5 µg/day ÷ serving size
Cadmium (Cd)	≤ 0.5 ppm	Prop 65 MADL: 4.1 µg/day
Arsenic (As)	≤ 2.0 ppm (total), speciation if elevated	Inorganic As is the concern
Mercury (Hg)	≤ 0.2 ppm	Rarely elevated in ashwagandha

Run ICP-MS per USP <233> on every incoming lot. Do not skip this because the supplier CoA shows passing — we have seen supplier results and our results disagree by 3–5x on the same lot, typically due to differences in digestion completeness.

Stability: withanolides degrade, and your shelf life depends on proving they don’t

Withanolides are susceptible to oxidation and hydrolysis under accelerated conditions. Brands claiming 24-month shelf life need stability data showing withanolide content holds above label claim at 25°C/60% RH (long-term) and 40°C/75% RH (accelerated) per ICH Q1A guidelines.

Common stability failures we have seen:

• Capsules with hygroscopic excipients that absorb moisture and accelerate withanolide degradation — 18% potency loss at 12 months in one study we supported
• Overages set too low — brands using 5% overage when stability data supports 10–15% loss over shelf life
• No finished-product stability — only raw material data, which does not represent the actual product consumers purchase

Practical checklist for your next ashwagandha lot

1. Confirm plant part on your spec. If your label says “root,” your HPTLC fingerprint should match root reference material — not a root-plus-leaf composite.

2. Lock your HPLC method to your extract type. KSM-66, Sensoril, and generic extracts need different analytical approaches. Do not use one method for all three.

3. Run allergen screening on new suppliers. ELISA for peanut and soy at minimum. Document results in your supplier qualification file.

4. Set elemental limits by serving size. Calculate Prop 65 exposure from your actual daily dose, not a generic pass/fail.

5. Build stability around the finished form. Include withanolide potency, not just appearance and dissolution, at 6, 12, 18, and 24 months.

6. Keep chromatograms. Store raw HPLC data files for at least one year beyond product expiry. If an auditor asks “how do you know this is ashwagandha root?”, your answer should be a chromatogram overlay, not a supplier email.

Ashwagandha is not “one ingredient” — it is a category of extracts with different chemistry, different safety profiles, and different analytical requirements. Testing that treats them generically produces CoAs that look complete but prove nothing specific.

See how botanical supplement testing and analytical chemistry support ashwagandha programs, or read the complete brand guide to lab testing for supplements.

Editorial scope

This article summarizes common lab-testing considerations for brands and is not a substitute for product-specific regulatory or legal advice. Method availability and accreditation scope vary by project — confirm with Qalitex before relying on a test menu for release or registration.